BRPI0921649A2 - sais de [4-(6-flúor-7-metil-amino-2-4-dioxo-1,4-dioxo-1,4-diidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-sulfonilureia, formas e métodos relacionados a eles - Google Patents

sais de [4-(6-flúor-7-metil-amino-2-4-dioxo-1,4-dioxo-1,4-diidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-sulfonilureia, formas e métodos relacionados a eles

Info

Publication number
BRPI0921649A2
BRPI0921649A2 BRPI0921649A BRPI0921649A BRPI0921649A2 BR PI0921649 A2 BRPI0921649 A2 BR PI0921649A2 BR PI0921649 A BRPI0921649 A BR PI0921649A BR PI0921649 A BRPI0921649 A BR PI0921649A BR PI0921649 A2 BRPI0921649 A2 BR PI0921649A2
Authority
BR
Brazil
Prior art keywords
dioxo
quinazolin
sulfonylurea
thiophen
dihydro
Prior art date
Application number
BRPI0921649A
Other languages
English (en)
Inventor
Anjali Pandey
Emma Sharp
Juan Wang
Louisa Jane Quegan
Matthew Nieder
Wolin Huang
Original Assignee
Portola Pharmaceutiacals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41460405&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0921649(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Portola Pharmaceutiacals Inc filed Critical Portola Pharmaceutiacals Inc
Publication of BRPI0921649A2 publication Critical patent/BRPI0921649A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0921649A 2008-11-05 2009-11-04 sais de [4-(6-flúor-7-metil-amino-2-4-dioxo-1,4-dioxo-1,4-diidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-sulfonilureia, formas e métodos relacionados a eles BRPI0921649A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/265,699 US20090156620A1 (en) 2007-05-02 2008-11-05 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto
PCT/US2009/063313 WO2010054020A1 (en) 2008-11-05 2009-11-04 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto

Publications (1)

Publication Number Publication Date
BRPI0921649A2 true BRPI0921649A2 (pt) 2016-02-10

Family

ID=41460405

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921649A BRPI0921649A2 (pt) 2008-11-05 2009-11-04 sais de [4-(6-flúor-7-metil-amino-2-4-dioxo-1,4-dioxo-1,4-diidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-sulfonilureia, formas e métodos relacionados a eles

Country Status (14)

Country Link
US (2) US20090156620A1 (pt)
EP (1) EP2358706A1 (pt)
JP (1) JP2012508243A (pt)
KR (1) KR20110093843A (pt)
CN (1) CN102272130A (pt)
AR (1) AR075097A1 (pt)
AU (1) AU2009313565A1 (pt)
BR (1) BRPI0921649A2 (pt)
CA (1) CA2742601A1 (pt)
CL (1) CL2009002040A1 (pt)
MX (1) MX2011004841A (pt)
RU (1) RU2011122385A (pt)
TW (1) TW201022252A (pt)
WO (1) WO2010054020A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1951254E (pt) * 2005-11-03 2012-04-12 Portola Pharm Inc [4-(6-halo-7-substituído-2,4-dioxo-1,4-di-hidro-2hquinazolin- 3-il)-fenil]-5-cloro-tiofen-2-il-sulfonilureias e formas e métodos relacionados com as mesmas
WO2008137809A2 (en) * 2007-05-02 2008-11-13 Portola Pharmaceuticals, Inc. [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof
US20130165459A1 (en) 2010-01-12 2013-06-27 Norvartis Pharma Ag Pharmaceutical composition and dosage forms of elinogrel and methods of use thereof
JP2013544271A (ja) * 2010-12-03 2013-12-12 ポートラ ファーマシューティカルズ， インコーポレイテッド 式（ｉ）の化合物の薬学的組成物、投薬形態、および新規の形態、ならびにその使用方法
CN103288761B (zh) * 2012-02-25 2017-08-11 浙江华海药业股份有限公司 一种合成1，2，3，4‑喹唑啉‑2，4‑二酮衍生物的新方法
AU2017364349A1 (en) * 2016-11-28 2019-07-11 Sarin PARAYIL Novel organic crystalline salt of haloacetic acid
CN115490643A (zh) * 2022-11-21 2022-12-20 南京合创药业有限公司 一种一锅法合成3-二氯苯基-6-氟-2,4(1h,3h)-喹唑啉二酮的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6906063B2 (en) * 2000-02-04 2005-06-14 Portola Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
PT1951254E (pt) * 2005-11-03 2012-04-12 Portola Pharm Inc [4-(6-halo-7-substituído-2,4-dioxo-1,4-di-hidro-2hquinazolin- 3-il)-fenil]-5-cloro-tiofen-2-il-sulfonilureias e formas e métodos relacionados com as mesmas
WO2008137809A2 (en) * 2007-05-02 2008-11-13 Portola Pharmaceuticals, Inc. [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof
CA2686203A1 (en) * 2007-05-02 2008-11-13 Portola Pharmaceuticals, Inc. Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor

Also Published As

Publication number Publication date
CN102272130A (zh) 2011-12-07
AR075097A1 (es) 2011-03-09
WO2010054020A1 (en) 2010-05-14
US20090156620A1 (en) 2009-06-18
EP2358706A1 (en) 2011-08-24
KR20110093843A (ko) 2011-08-18
JP2012508243A (ja) 2012-04-05
RU2011122385A (ru) 2012-12-20
MX2011004841A (es) 2011-07-28
AU2009313565A1 (en) 2010-05-14
US20120129876A1 (en) 2012-05-24
CA2742601A1 (en) 2010-05-14
CL2009002040A1 (es) 2010-09-10
TW201022252A (en) 2010-06-16

Similar Documents

Publication Publication Date Title
BRPI0918046A2 (pt) gerenciamento de autenticação de usuário
BRPI0810800A2 (pt) Sais de [4-(6-fluoro-7-metilamino-2,4-dioxo-1, 4-diidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-s ulfonilureia, formas e métodos relacionados a eles.
NO2021006I1 (no) Quofenix, delafloksacin
FR2919196B1 (fr) Descendeur autobloquant a poignee debrayable.
PL2354161T3 (pl) Przeciwciało anty -NR10 i jego zastosowanie
LT3216803T (lt) Stabilūs ir tirpūs antikūnai, slopinantys vegf
BRPI0923409A2 (pt) cabeça de escova de dentes, e, escova de dentes.
BRPI0917258A2 (pt) composição reforçadora, e, composição detergente
BRPI0921649A2 (pt) sais de [4-(6-flúor-7-metil-amino-2-4-dioxo-1,4-dioxo-1,4-diidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-sulfonilureia, formas e métodos relacionados a eles
EP2238853A4 (en) BUCKLE
DK2200985T3 (da) 1,3-Disubstituerede 4-(aryl--X-phenyl)-1H-pyridin-2-oner
BRPI0912799A2 (pt) fluxímetro, e, método
IT1397663B1 (it) Bocchettone e procedimento per la sua fabbricazione.
EP2230588A4 (en) Communication terminal and program
BRPI0913112A2 (pt) fluxímetro, e, método.
FI20096186A0 (fi) Pinnoitettu puumateriaali, sen valmistusmenetelmä sekä käyttö
EP1951254A4 (en) [(2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL) -PHENYL] -5-CHLORO-THIOPHENE-2-YL-SULFONYLUREES [4- (6-HALO-7-SUBSTITUTEES)] AND ASSOCIATED FORMS AND METHODS
BRPI0909060A2 (pt) descobrindo vizinhos em redes de área pessoal sem fio.
AP2011005981A0 (en) Synthetic hair fiber, usage thereof, and manufacturing method therefor.
BRPI0914584A2 (pt) Método, e, composição herbicida.
DK2296473T3 (da) Virksomt 4-(3-alkylsulfinylbenzoyl) pyrazol-herbicid
FR2927552B1 (fr) Pulverisateur, notamment a usage medical
SI2354161T1 (sl) Anti-NR10 protitelo in njegova uporaba
BRPI0807992A2 (pt) Sais de adição do ácido, hidratos e polimorfos de etilamida do ácido 5-(2-4-di-hidróxi-5-isopropil-fenil)-4-(4-morfolin-4-ilme til-fenil) isoxazol-3-carboxílico e formulações compreendendo essas formas.
PT2277578T (pt) Nebulizador.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]